Enlivex Therapeutics Ltd. buy melinda
Start price
27.01.17
/
50%
€47.63
Target price
27.07.17
€72.16
Performance (%)
-53.77%
End price
27.07.17
€22.02
Summary
This prediction ended on 27.07.17 with a price of €22.02. The BUY prediction by melinda for Enlivex Therapeutics Ltd. performed very badly with a performance of -53.77%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Enlivex Therapeutics Ltd. | -2.632% | -2.632% | -50.885% | -89.722% |
iShares Core DAX® | 3.054% | -1.396% | 15.789% | 12.675% |
iShares Nasdaq 100 | 4.389% | -5.391% | 29.906% | 39.325% |
iShares Nikkei 225® | 5.386% | -3.105% | 16.065% | 8.150% |
iShares S&P 500 | 2.955% | -3.011% | 25.903% | 37.650% |
Comments by melinda for this prediction
In the thread Enlivex Therapeutics Ltd. diskutieren
Phase LE2 / 02/2017
folgen
(Laufzeit überschritten)
Stopped prediction by melinda for Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€21.20
25.10.17
25.10.17
€22.40
20.12.17
20.12.17
6.79%
20.12.17
20.12.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€19.12
25.10.17
25.10.17
€20.20
20.12.17
20.12.17
6.79%
20.12.17
20.12.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€14.65
26.09.17
26.09.17
€18.04
28.09.17
28.09.17
13.71%
28.09.17
28.09.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€16.24
26.09.17
26.09.17
€20.00
28.09.17
28.09.17
13.71%
28.09.17
28.09.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€185.81
14.10.15
14.10.15
€234.52
14.04.16
14.04.16
-54.95%
14.04.16
14.04.16